经颈静脉肝内门体分流术联合胃左静脉栓塞术治疗肝硬化食管胃底静脉曲张破裂出血初步临床研究

doi:10.3969/j.issn.1672-5069.2017.02.031

Abstract

Chen Zhijuan， Si Yi， Jin Rui， et al.. Transjugular intrahepatic portosystemic shunts and left gastric vein embolization in treatment of cirrhotic patients with esophageal and gastric variceal bleeding[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 238-239.

References

[1] 中华医学会消化内镜学分会.食管胃静脉曲张内镜下诊断和治疗规范试行方案（2003年）. 中华消化内镜杂志，2004，21:149-151.
[2] 陈春，伍思国，杨智娟.肝硬化上消化道出血患者预后因素分析.实用肝脏病杂志，2015，18（3）：300-301.
[3] Rahimi RS，Rockey DC.Complications and outcomes in chronic liver disease. Curr Opin Gastroententerol，2011，27（3）:204-209.
[4] Tripathi D，Therapondos G，Jackson E，et al. The role of transjugular intrahepatic portosystemic stent shunt（TIPSS） in the management of bleeding gastric varices:Clinical and haemodynamic correlations. Gut，2002，51（2）:270-274.
[5] 薛挥，吕梁山，郝志明，等. 经颈静脉肝内门腔静脉内支架分流术（TIPSS）治疗门脉高压症（附215例分析）. 中国现代医学杂志，2007；17（15）:1863-1869.
[6] Grace ND.Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol，1997，92（7）:1081-1091.
[7] Garcia-Tsao G，Sanyal AJ，Grace ND，et al. Prevention and manage-ment of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology，2007，46（3）:922-938.
[8] Coldwell DM，Ring EJ，Ree CR，et al. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology，1995，196（2）:335-340.
[9] Shiffman ML，Jeffers L，Hoofnagle JH，et al. The role of transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension and its complication:a conference of sponsored by the National Digestive Disease Advisory Board.Hepatology，1995，22（5）:1591-1597.
[10] Kaare T，Thomas F，Christel W，et al. Transjugular intrahepatic portosystemic shunts:Adjunctive embolotherapy of gastro - esophageal collateral vessels in the prevention of variceal rebleeding. Radiology，2005，236（1）:360-367.
[11] Smith-Laing G，Scott J，Long RG，et al. Role of percutaneous transhepatic obliteration of varices in the management of hemorrhage from gastroesophageal varices. Gastroenterology，1981，80（5）:1031-1036.
[12] Takase Y，Shibuya S，Chikamori F，et al. Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for oesophageal varices. Hepatology，1990，11（3）:348-353.
[13] 向谦，李肖，张铭光，等. 采用覆膜支架经颈静脉肝内门体分流术改善术后分流道狭窄及门静脉高压的系统评价. 中国实用内科杂志，2008，28（3）:190-193.
[14] Chang CJ，Hou MC，Liao WC，et al.Management of acute gastric varices bleeding. J Chin Med Assoc，2013，76（10）:539-546.
[15] Ryan BM，Stockbrugger RW，Ryan JM.A pathophysiologic，gastroenterologic，and radiologic approach to the management of gastric varices. Gastroenterology，2004，126（4）:1175-1189.

Transjugular intrahepatic portosystemic shunts and left gastric vein embolization in treatment of cirrhotic patients with esophageal and gastric variceal bleeding

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[3]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[4]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[5]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[6]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[7]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[8]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[9]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[12]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[13]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[14]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[15]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.